ASSETMARK, INC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1344551 CONCORD, CA

Position in ARWR

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$183,397

+$28,528 QoQ

Shares Held

2,250

-8.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#381

of 497 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ASSETMARK, INC holds $347,870,398 across 92 Biotechnology names. ARWR ranks #37 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	3,433,824	$186,834,363
2	VRTX	Vertex Pharmaceuticals Inc / Ma	61,055	$30,327,850
3	DFTX	Definium Therapeutics, Inc.	396,542	$18,653,335
4	HALO	Halozyme Therapeutics, Inc.	174,334	$13,645,122
5	PTGX	Protagonist Therapeutics, Inc	98,687	$12,097,052
6	ONC	BeOne Medicines Ltd.	32,399	$9,232,743
7	REGN	Regeneron Pharmaceuticals, Inc.	12,594	$7,852,862
8	ARGX	Argenx SE	7,699	$7,142,901

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$183,397	2,250	-8.9%	Shares	Sole	2026-07-30
2026-03-31	$154,869	2,470	+896.0%	Shares	Sole	2026-05-06
2025-12-31	$16,464	248	+675.0%	Shares	Sole	2026-01-23
2025-09-30	$1,103	32	+433.3%	Shares	Sole	2025-11-06
2024-12-31	$112	6	-100.0%	Shares	Sole	2025-02-06
2023-06-30	$2,093,135	58,697	+3.8%	Shares	Defined	2023-08-11
2023-03-31	$1,436,344	56,549	-32.7%	Shares	Defined	2023-05-05
2022-12-31	$3,405,620	83,965	+6.5%	Shares	Defined	2023-02-10
2022-09-30	$2,606,884	78,877	+13.6%	Shares	Sole	2022-11-01
2022-06-30	$2,445,545	69,456	+33.6%	Shares	Sole	2022-08-03
2022-03-31	$2,390,054	51,969	+86.9%	Shares	Sole	2022-05-13
2021-12-31	$1,843,471	27,805	+1962.7%	Shares	Sole	2022-02-14
2021-09-30	$84,155	1,348	+12154.5%	Shares	Sole	2021-11-12
2020-06-30	$475	11	0.0%	Shares	Sole	2020-08-11
2020-03-31	$316	11	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.